Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will be presenting and hosting 1x1 investor meetings at the 46th Annual TD Cowen Health Care Conference in Boston, MA.
Presentation: Monday, March 2, 2026 at 9:50am – 10:20 am ET
Location: Regis
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
How Morgan Stanley, TD Cowen, Citibank Are Embracing Bitcoin
Cardano Price Prediction: ADA Drops, BTC Miners Start Selling, All While DeepSnitch AI Raises $1.9M+ Ahead of the March 31 Launch
Jobs Report Just Dented Most Bulletproof Sector ETF In The Market
Letter to Shareholders from CEO Dr. Ryan Saadi
Trending news
MoreCrypto prices
More
